In the last few years, progress has been made in the fight against Alzheimer's disease with a class of therapies called ...

Despite reported slowing of progression, regulators said the evidence on the novel oral agent blarcamesine did not support a ...

Alzheimer's trials testing Novo Nordisk’s blockbuster GLP-1 drug semaglutide, despite their failure, underscore a shift to ...

Recent clinical trials of Novo Nordisk’s blockbuster GLP-1 drug semaglutide for Alzheimer’s disease may have failed to show ...

Alzheimer's trials testing Novo Nordisk’s blockbuster GLP-1 drug semaglutide, despite their failure, underscore a shift to ...

Anavex Life Sciences Corp. ('Anavex” or the 'Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's ...

Experts concluded the drug, which slows the progression of the disease for some people, did not have therapeutic value ...

Doctors are increasingly alarmed that a type of dementia which closely resembles Alzheimer's may have resulted in the ...

New research shows that blood from older animals can speed up Alzheimer’s-related changes in the brain, while young blood may ...

A recent study from the University of California San Diego has found a new lead. The researchers discovered that an enzyme in ...

Michael Jeffries, 81, has been restored to a level of competency needed for his sex trafficking trial to move forward, ...

First Patient Expected to be Dosed Next Week with Intranasal ForalumabPET Scan Shows Presence of Untreated Neuroinflammation ...